Form 4: Director McNamara Acquires 10,000 Shares of AVITA Medical, Inc. (RCEL)
SEC Form 4
Robert McNamara, a director of AVITA Medical, Inc., acquired 10,000 shares of common stock at $9 per share on August 19, 2024, and disposed of 35,749 shares.
Summary
- On August 19, 2024, Robert McNamara, a director of AVITA Medical, Inc. (RCEL), acquired 10,000 shares of common stock.
- The acquisition price was $9 per share.
- Following the transaction, McNamara directly owns 35,749 shares of AVITA Medical, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in trading activities by company insiders. This allows the market to stay informed about the actions of key individuals within a company.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company directors as it can provide insights into their perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Date of transaction: Robert McNamara acquired 10,000 shares of AVITA Medical, Inc. common stock and disposed of 35,749 shares. |
| 08/20/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.